Farag Kameel D.
Transaction: 08/17/2026
BUY
Change
+1,728
Price
$7.52
Filing
08/19/2026
Type
BUY
Akari Therapeutics, Plc
AKTX • Biotechnology
$11.47
▲ +0.63 (+5.81%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$205,473.58
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Weak liquidity · 0.44Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.47
Change5.81%
Shares Out17.91K
Market Cap$205.47K
Enterprise Value$-6.80M
52W Range3.02 - 49.60
Beta1.39
P/E-0.01
P/B0.01
P/FCF-0.02
EV/EBITDA0.21
EV/FCF0.63
Price$11.47
Change5.81%
Shares Out17.91K
Market Cap$205.47K
Enterprise Value$-6.80M
52W Range3.02 - 49.60
Beta1.39
P/E-0.01
P/B0.01
P/FCF-0.02
EV/EBITDA0.21
EV/FCF0.63
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio0.44
Quick Ratio0.44
Target$30.00
Target Upside161.55%
Target Median$30.00
Target Range30.00 - 30.00
Volume15.21K
Avg Volume795.34K
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.03Weak liquidity · 0.44Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
94/100
Bullish
Bullish
7
Hold
1
Bearish
0
Price Target
2026-08-20
Low
$30.00
Mean
$30.00
Median
$30.00
High
$30.00
Insider Transactions
Recent executive and insider activity
Farag Kameel D.
Transaction: 07/16/2026
BUY
Change
+1,130
Price
$11.50
Filing
08/05/2026
Type
BUY
Patel Samir Rashmikant
Transaction: 07/07/2026
BUY
Change
+5,799
Price
$0.00
Filing
07/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Farag Kameel D. | BUY | +1,728 | $7.52 | 08/17/2026 | 08/19/2026 |
| Farag Kameel D. | BUY | +1,130 | $11.50 | 07/16/2026 | 08/05/2026 |
| Patel Samir Rashmikant | BUY | +5,799 | $0.00 | 07/07/2026 | 07/17/2026 |
| Patel Samir Rashmikant | BUY | +1,209 | $8.00 | 07/07/2026 | 07/17/2026 |
| Patel Samir Rashmikant | BUY | +1,209 | $8.00 | 07/07/2026 | 07/17/2026 |
| Gaslightwala Abizer | BUY | +5,500 | $4.64 | 06/24/2026 | 06/25/2026 |
| Farag Kameel D. | BUY | +1,248 | $10.02 | 06/24/2026 | 06/25/2026 |
| Neal James R | BUY | +2,473 | $0.39 | 12/16/2025 | 03/16/2026 |
| Neal James R | BUY | +2,473 | Not reported | 12/16/2025 | 03/16/2026 |
| Neal James R | BUY | +3,093 | $0.39 | 12/16/2025 | 03/16/2026 |
| Bazemore Robert B | BUY | +30,932 | $0.39 | 12/16/2025 | 12/18/2025 |
| Bazemore Robert B | BUY | +30,932 | Not reported | 12/16/2025 | 12/18/2025 |
| Bazemore Robert B | BUY | +123,731 | $0.39 | 12/16/2025 | 12/18/2025 |
| Gaslightwala Abizer | BUY | +309,328 | $0.39 | 12/16/2025 | 12/18/2025 |
| Gaslightwala Abizer | BUY | +309,328 | Not reported | 12/16/2025 | 12/18/2025 |
| Gaslightwala Abizer | BUY | +773,323 | $0.39 | 12/16/2025 | 12/18/2025 |
| Patel Samir Rashmikant | BUY | +231,997 | $0.39 | 12/16/2025 | 12/18/2025 |
| Patel Samir Rashmikant | BUY | +231,997 | Not reported | 12/16/2025 | 12/18/2025 |
| Patel Samir Rashmikant | BUY | +618,658 | $0.39 | 12/16/2025 | 12/18/2025 |
| Farag Kameel D. | BUY | +24,745 | Not reported | 12/16/2025 | 12/18/2025 |